Vasanthi S. Viswanathan

12.9k total citations · 3 hit papers
10 papers, 7.7k citations indexed

About

Vasanthi S. Viswanathan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Vasanthi S. Viswanathan has authored 10 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Organic Chemistry. Recurrent topics in Vasanthi S. Viswanathan's work include Ferroptosis and cancer prognosis (4 papers), Click Chemistry and Applications (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Vasanthi S. Viswanathan is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Click Chemistry and Applications (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Vasanthi S. Viswanathan collaborates with scholars based in United States, Germany and Japan. Vasanthi S. Viswanathan's co-authors include Stuart L. Schreiber, Paul A. Clemons, Clary B. Clish, Jaime H. Cheah, Brent R. Stockwell, Kaoru Shimada, Lewis M. Brown, Rohitha Sriramaratnam, Albert W. Girotti and Virginia W. Cornish and has published in prestigious journals such as Nature, Cell and Journal of the American Chemical Society.

In The Last Decade

Vasanthi S. Viswanathan

10 papers receiving 7.6k citations

Hit Papers

Regulation of Ferroptotic Cancer Cell Death by GPX4 2014 2026 2018 2022 2014 2017 2019 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regulation of Ferroptotic Cancer Cell Death by GPX4
    2014 5.5k citations Wan Seok Yang, Rohitha Sriramaratnam et al. Cell profile →
  2. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
    2017 1.2k citations Matthew J. Hangauer, Vasanthi S. Viswanathan et al. Nature profile →
  3. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
    2019 663 citations Yilong Zou, Michael J. Palte et al. Nature Communications profile →

Peers

Vasanthi S. Viswanathan
Guang Lei United States
Matthew Welsch United States
Rohitha Sriramaratnam Switzerland
Pranavi Koppula United States
John K. Eaton United States
Leslie Magtanong United States
Jiajun Zhu United States
Prashant Monian United States
Hyemin Lee United States
Yangyang Yu China
Guang Lei United States
Vasanthi S. Viswanathan
Citations per year, relative to Vasanthi S. Viswanathan Vasanthi S. Viswanathan (= 1×) peers Guang Lei

Countries citing papers authored by Vasanthi S. Viswanathan

Since Specialization
Citations

This map shows the geographic impact of Vasanthi S. Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasanthi S. Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasanthi S. Viswanathan more than expected).

Fields of papers citing papers by Vasanthi S. Viswanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasanthi S. Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasanthi S. Viswanathan. The network helps show where Vasanthi S. Viswanathan may publish in the future.

Co-authorship network of co-authors of Vasanthi S. Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Vasanthi S. Viswanathan. A scholar is included among the top collaborators of Vasanthi S. Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasanthi S. Viswanathan. Vasanthi S. Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Garcia-Rivera, Enrique, Dylan C. Mitchell, Joel M. Chick, et al.. (2025). Highly specific intracellular ubiquitination of a small molecule. Nature Chemical Biology. 1 indexed citations
2.
Moosmayer, Dieter, A. Hilpmann, Katja Zimmermann, et al.. (2021). Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162. Acta Crystallographica Section D Structural Biology. 77(2). 237–248. 89 indexed citations
3.
Eaton, John K., Laura Furst, Luke L. Cai, Vasanthi S. Viswanathan, & Stuart L. Schreiber. (2020). Structure–activity relationships of GPX4 inhibitor warheads. Bioorganic & Medicinal Chemistry Letters. 30(23). 127538–127538. 45 indexed citations
4.
Zou, Yilong, Michael J. Palte, Amy Deik, et al.. (2019). A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nature Communications. 10(1). 1617–1617. 663 indexed citations breakdown →
5.
Eaton, John K., et al.. (2019). Diacylfuroxans Are Masked Nitrile Oxides That Inhibit GPX4 Covalently. Journal of the American Chemical Society. 141(51). 20407–20415. 97 indexed citations
6.
Hangauer, Matthew J., Vasanthi S. Viswanathan, Matthew J. Ryan, et al.. (2017). Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 551(7679). 247–250. 1204 indexed citations breakdown →
7.
Hangauer, Matthew J., Vasanthi S. Viswanathan, Matthew J. Ryan, et al.. (2017). Abstract 1006: Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Cancer Research. 77(13_Supplement). 1006–1006. 2 indexed citations
8.
Bošković, Žarko, Melissa M. Kemp, Allyson M. Freedy, et al.. (2016). Inhibition of Zinc-Dependent Histone Deacetylases with a Chemically Triggered Electrophile. ACS Chemical Biology. 11(7). 1844–1851. 24 indexed citations
9.
Viswanathan, Vasanthi S.. (2015). Cellular features predicting susceptibility to ferroptosis: insights from cancer cell-line profiling. Columbia Academic Commons (Columbia University). 2 indexed citations
10.
Yang, Wan Seok, Rohitha Sriramaratnam, Matthew Welsch, et al.. (2014). Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell. 156(1-2). 317–331. 5536 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang Lei Breakdown of academic impact, for papers by Matthew Welsch Breakdown of academic impact, for papers by Rohitha Sriramaratnam Breakdown of academic impact, for papers by Pranavi Koppula Breakdown of academic impact, for papers by John K. Eaton Breakdown of academic impact, for papers by Leslie Magtanong Breakdown of academic impact, for papers by Jiajun Zhu Breakdown of academic impact, for papers by Prashant Monian Breakdown of academic impact, for papers by Hyemin Lee Breakdown of academic impact, for papers by Yangyang Yu
Rankless by CCL
2026